The 12 references in paper Yu. Olefir V., T. Bokovikova N., L. Stronova A., E. Gernikova P., L. Mitkina I., S. Manaeva A., Yu. Purim B., A. Pichugin V., Ю. Олефир В., Т. Боковикова Н., Л. Стронова А., Е. Герникова П., Л. Митькина И., С. Манаева А., Ю. Пурим Б., А. Пичугин В. (2018) “Определение видимых механических включений в лекарственных формах для парентерального применения и глазных лекарственных формах // Determination of visible particles in parenteral dosage forms and ophthalmic dosage forms” / spz:neicon:vedomostincesmp:y:2016:i:1:p:37-40

1
Braun B. Melsungen AG Hospital Care. Particulate Contamination Risk Prevention in Infusion Therapy. Sharing expertise. Available from: http:// www.safeinfusiontherapy.com/.
(check this in PDF content)
2
Grunewald M. Pflege von Patienten mit Erkrankungen des HerzKreislauf-und Gefassystems. In: Kellnhauser E, Schewior-Popp, et al. Thiemes Pflege. Stuttgart, New York; 2004. Ð. 316–17.
(check this in PDF content)
3
General pharmacopoeial article «Visible mechanical inclusion in the formulations for parenteral and ophthalmic dosage forms» (in Russian).
(check this in PDF content)
4
The State Pharmacopoeia of Republic of Belarus. 1st ed. V. 1. Minsk: Tsentr ekspertiz i ispytaniy v zdravoohranenii; 2006 (in Russian).
(check this in PDF content)
5
The State Pharmacopoeia of Republic of Kazakhstan. 1st ed. V. 1. Almaty: Zhibek Zholy; 2008 (in Russian).
(check this in PDF content)
6
European Pharmacopoeia. 8th edition. European Directorate for the Quality of Medicines and Healthcare (EDQM). Available from: http:// online.edqm.eu/entry.htm.
(check this in PDF content)
7
United States Pharmacopeia. 35th ed. United States Pharmacopeial Convention. Available from: http:// www.uspnf.com/uspnf/login.
(check this in PDF content)
8
The Japanese Pharmacopeia. 16th ed. Pharmaceuticals and medical devices agency. Available from: http:// www.pmda.go.jp/english/.
(check this in PDF content)
9
British Pharmacopoeia. British Pharmacopoeia Commission. Available from: http:// www.pharmacopoeia.co.uk/.
(check this in PDF content)
10
Annex III to the British Pharmacopoeia «SC I N. Particulate Contamination».
(check this in PDF content)
11
Working document WHO QAS/11.405.
(check this in PDF content)
12
The International Pharmacopoeia. 4th ed. World Health Organization. Available from: http://apps.who.int/phint/en/p/about/. AUTHORS Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation, Petrovsky boulevard, 8–2, Moscow, 127051, Russian Federation.
(check this in PDF content)